Company news
Veracyte, Inc. news in 2019
Veracyte, Inc.'s news releases, calls and decks from 2019, newest first.
Veracyte Acquires Exclusive License to NanoString Diagnostics Platform, Positioning Veracyte To Expand Its Genomic Testing Business Globally
December 2, 2019
Veracyte Announces New Data That Advance Understanding of Genomic Alterations Targeted by Precision Medicine Therapies for Thyroid Cancer
November 1, 2019
Veracyte Announces New Data Characterizing Genomic Alterations in Thyroid Cancer To Be Presented at 89th Annual Meeting of the American Thyroid Association
October 29, 2019
Veracyte Announces Third Quarter 2019 Financial Results and Business Progress
October 21, 2019
Veracyte Announces Clinical Data Demonstrating Clinical Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis When Bronchoscopy Results Are Inconclusive
October 20, 2019
Veracyte Announces Publication of Clinical and Analytical Validation Data for Afirma Xpression Atlas
September 10, 2019
Decks in 2019
- Investor Presentation (October 2019)
Investor deck · 17 slides · Oct 22, 2019